MIR152, microRNA 152, 406943

N. diseases: 136; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 AlteredExpression disease BEFREE LINC00339 exerted oncogenesis effect on HCC progression by targeting miR-152/ROCK1, and the expression of LINC00339 was negatively correlated with miR-152 expression and positively correlated with ROCK1 expression in clinical HCC samples. 31081143 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 Biomarker disease BEFREE Both CDK8 and miR-152-3p could serve as the independent prognostic factors for predicting the OS and DFS in HCC patients. 30967300 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 AlteredExpression disease BEFREE We found higher signals for miR-122 and miR-152 in non-tumor liver and HCC tissues compared to control tissues. 28512857 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 Biomarker disease BEFREE HBx represses RIZ1 expression by DNA methyltransferase 1 involvement in decreased miR-152 in hepatocellular carcinoma. 28339081 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 Biomarker disease BEFREE MicroRNA-152 inhibits tumor cell growth by directly targeting RTKN in hepatocellular carcinoma. 27922690 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 Biomarker disease BEFREE And high expression of HLA-G further suppressed NK against cancer cells, providing a new concept that miR-152 was involved in HBV-induced hepatocellular carcinoma. 26468017 2016
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 Biomarker disease BEFREE This suggests that miR-152-specific targeting of TFRC may provide a selective anticancer therapeutic approach for the treatment of HCC. 26657500 2016
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 Biomarker disease BEFREE Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells. 24998573 2014
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 Biomarker disease BEFREE These findings support a tumor-suppressive role of miR-152 in the epigenetic aberration of HBV-related HCC and the potential development of miRNA-based targeted approaches for the treatment of HBV-related HCC. 20578129 2010